We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
Cap. Flow
+$363M
Cap. Flow %
13.21%
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$36.2M
2
HYFM icon
Hydrofarm Holdings
HYFM
+$19.6M
3
LUNG icon
Pulmonx
LUNG
+$19.2M
4
SEER icon
Seer Inc
SEER
+$18.7M
5
ABCL icon
AbCellera Biologics
ABCL
+$16.7M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$27M
2
INSP icon
Inspire Medical Systems
INSP
+$11.3M
3
PPD
PPD, Inc. Common Stock
PPD
+$11.1M
4
STAA icon
STAAR Surgical
STAA
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$9.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.42%
2 Industrials 1.65%
3 Consumer Staples 0.32%
4 Financials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSP icon
201
CALL
Inspire Medical Systems
INSP
$1.68B
– –
-65,000
Closed -$8.39M
ISRG icon
202
PUT
Intuitive Surgical
ISRG
$142B
– –
-45,000
Closed -$10.6M
KRMD icon
203
KORU Medical Systems
KRMD
$152M
– –
-408,516
Closed -$2.95M
LAB icon
204
Standard BioTools
LAB
$312M
– –
-812,757
Closed -$6.04M
LQDA icon
205
Liquidia Corp
LQDA
$7.01B
– –
-100,000
Closed -$492K
LSF icon
206
Laird Superfood
LSF
$46.8M
– –
-150,000
Closed -$6.88M
LYRA
207
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-4,534
Closed -$2.54M
MASI
208
PUT
DELISTED
Masimo
MASI
– –
-55,000
Closed -$13M
MMM icon
209
CALL
3M
MMM
$94.8B
– –
-47,840
Closed -$6.41M
MRNA icon
210
CALL
Moderna
MRNA
$25.4B
– –
-100,000
Closed -$7.08M
OSUR icon
211
CALL
OraSure Technologies
OSUR
$259M
– –
-310,200
Closed -$3.77M
PRLD icon
212
Prelude Therapeutics
PRLD
$456M
– –
-5,000
Closed -$151K
RAPT
213
DELISTED
RAPT Therapeutics
RAPT
– –
-6,250
Closed -$1.61M
RCL icon
214
CALL
Royal Caribbean
RCL
$82.4B
– –
-50,000
Closed -$3.24M
FLNA
215
CALL
Filana Therapeutics
FLNA
$45.1M
– –
-50,000
Closed -$576K
SVRA icon
216
Savara
SVRA
$1.17B
– –
-266,570
Closed -$291K
TECH icon
217
PUT
Bio-Techne
TECH
$11.3B
– –
-100,000
Closed -$6.19M
TMDX icon
218
PUT
Transmedics
TMDX
$3.02B
– –
-75,000
Closed -$1.03M
TSHA icon
219
Taysha Gene Therapies
TSHA
$2.05B
– –
-10,000
Closed -$224K
TWST icon
220
Twist Bioscience
TWST
$7.85B
– –
-57,581
Closed -$6.39M
NVRO
221
DELISTED
NEVRO CORP.
NVRO
– –
-31,838
Closed -$5.16M
ITCI
222
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-150,000
Closed -$3.85M
CUTR
223
DELISTED
Cutera, Inc.
CUTR
– –
-183,275
Closed -$3.48M
PSTX
224
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-148,949
Closed -$1.32M
NVTA
225
DELISTED
Invitae Corporation
NVTA
– –
-122,000
Closed -$5.29M
6 7 8
9
10

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.

  • Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
  • Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
  • Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
  • Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
  • Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
  • Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
  • Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.